Francis K. Lee, Ph.D. Senior Service Fellow (Research Microbiologist)

Slides:



Advertisements
Similar presentations
By Gracie Canales August 10, 2010
Advertisements

Christopher N. Greene, PhD Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 9th July 2013 Assay Quality.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
Assessing Laboratory Quality – Systematic Bias Robert O. Miller Colorado State University Fort Collins, CO.
The Effect of Unsatisfactory Specimens on Newborn Screening Lisa Kalman, PhD Newborn Screening Quality Assurance Program, CDC.
National Center for Environmental Health Centers for Disease Control and Prevention Carla Cuthbert, PhD, FACMG, FCCMG Chief, Newborn Screening and Molecular.
SACHDNC Meeting January 26/27, 2012 Nomination and Prioritization Workgroup Report on 22q11.2 Deletion Syndrome (22q11.2DS; DiGeorge Syndrome, DGS-1) Dietrich.
NBSTRN Update NCC/RC PI/PD Meeting November 19, 2010 Michael Watson.
Yi-Chen Yang, Drug Biology Division Bureau of Food and Drug Analysis Department of Health, Taiwan Collaborative study for establishment of the first national.
Karen Cristiano Biologicals Unit, CRIVIB Calibration against the WHO Standards of National Reference Preparations for detection of blood viruses by NAT:
National Center for Environmental Health Centers for Disease Control and Prevention DBS DNA Extraction, Validation & Quantitation NBS Molecular Training.
In Collaboration with NewSTEPs: Data collection efforts at the national level for newborn screening quality improvement Marci K Sontag, PhD NewSTEPs (Newborn.
Christopher N. Greene, PhD Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Thursday, July 11th, 2013 Molecular.
Molecular LDT in Newborn Screening Laboratories
Francis K. Lee, M.Sc, Ph.D. Senior Service Fellow (Research Microbiologist) Newborn Screening Translation Research Initiative, CDC Emeritus Professor of.
National Center for Environmental Health Centers for Disease Control and Prevention Carla D. Cuthbert, Ph.D. Chief, Newborn Screening and Molecular Biology.
Overview of Newborn Screening Laboratory Processes and Quality Management Scott M. Shone, PhD Program Manager New Jersey NBS Laboratory SACHDNC May 11,
Converting BCR-ABL1 to the International Scale: Standardizing the Measurement of Relative Gene Expression Charles E. Hill Emory University School of Medicine.
Blood bank visibility & functionality in the EMR Meghan Delaney, DO, MPH Medical Director, Blood Bank, Seattle Children’s Hospital Assistant Professor,
Abstract Automated, High-Throughput Total and Viral RNA Purification Byung-in Lee 1, Seachol Oak 1, Sharon Khietala 2, Beate Schikora 2, and Karl H Hecker.
Issues in the Measurement of Oxytocin Armando J. Mendez Department of Medicine Division of Endocrinology, Diabetes And Metabolism Miller School of Medicine.
National Center for Environmental Health Centers for Disease Control and Prevention Suzanne Cordovado, Ph.D. Team Lead, Molecular Quality Improvement Program.
REAL-TIME RT-PCR BASED ASSAY ON BLOOD CLOT SPECIMENS FOR DIAGNOSIS OF HIV-1 INFECTION IN CHILDREN, MALAWI Hua Yang 1, Rita Helfand 2, Desiree Witte 3,
Ensuring the Quality of Genetic Testing ICORD Meeting September 14, 2007 Lisa Kalman, PhD Coordinator, GeT-RM CDC
Grant Writing as a Teaching Tool in the Undergraduate Genetics Laboratory David P. Aiello Department of Biology Mercer University.
HIV, HCV, and HBV NAT Controls Formulation, Stability and Performance Mark Manak BBI Diagnostics, Inc. A Division of SeraCare Life Sciences, Inc. SoGAT.
Transmissibility of B19 by transfusion: evaluation of donor viremia prior to performing a linked donor-recipient study M Busch, representing REDS-II Parvo.
Call in number: Conference code: NBSTRN SCID National Call February 24, 2012.
Current Laboratory Practice Series Laboratory Practice Training Branch Division of Laboratory Systems Public Health Practice Program Office U.S. DEPARTMENT.
RESULTS Rapid testing started at one publicly funded counseling and testing site in New Jersey on November 1, Through December 31, 2004, 48 sites.
Persistent human erythrovirus infection in blood donors National Blood Service, UK Div. Transfusion Medicine, University of Cambridge, UK Public Health.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
David Y. Zhang MD, PhD, MPH Professor Director, Molecular Pathology Departments of Pathology Icahn School of Medicine at Mount Sinai, New York Molecular.
HIV diagnosis (general) ImmunoassaysNAT (PCR)
Yi-Chen Yang, Yu-Hsuan Chen, Show-Lan Chiu, Hwei-Fang Cheng Drug Biology Division, Bureau of Food and Drug Analysis Department of Health, Taiwan, ROC National.
Christopher N. Greene, PhD Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 28th June 2011 Molecular.
SoGAT XVII/Paris, 2004 Proficiency Testing of In-House Developed HIV-1 NAT for Blood Screening Michael Chudy, Paul-Ehrlich-Institut Division of Virology,
WHO EQAP for the detection of influenza A virus subtype by PCR Wilina Lim Centre for Health Protection Hong Kong SAR, China.
National Center for Environmental Health Centers for Disease Control and Prevention DNA Quantitation NBS Molecular Training Class June 28 – 30, 2011 Suzanne.
Molecular Detection of Karenia spp. in the Mid-Atlantic Kathryn J. Coyne 1, Edward Whereat 1, Muns Farestad 1, Jennifer Torora 1, Lauren Salvitti 1 and.
National Institute for Biological Standards and Control Assuring the quality of biological medicines Human Cytomegalovirus (HCMV) Proposed 1 st International.
Identify a Health Problem Qualitative Quantitative Develop Program -theory -objectives -format -content Determine Evaluation -design -sampling -measures.
Development of Standard Reagents for WNV NAT M. Rios, A. Grinev, K. Sirnivasan, O. Wood, S. Daniel, I. Hewlett CBER/FDA.
Unit 2-5 Notes Mr. Hefti – Pulaski Biology Genetic Testing.
Idea: measure the amount of mRNA to see which genes are being expressed in (used by) the cell. Measuring protein might be more direct, but is currently.
Gene Expression and Epigenetic Regulation JESSICA LAINE AND ELIZABETH MARTIN.
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
Evaluation Plan Steven Clauser, PhD Chief, Outcomes Research Branch Applied Research Program Division of Cancer Control and Population Sciences NCCCP Launch.
10 May Understanding diagnostic tests Evan Sergeant AusVet Animal Health Services.
Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Probe Validation Anne Wiktor September 21, Abnormalities identified by FISH.
National Institute for Biological Standards and Control Assuring the quality of biological medicines Bank Update II: focusing on contributions to R&D Lyn.
Module 9 Recording and reporting culture results Exercise 1.
Wendy Heck Grillo North Carolina Central University Dept. of Biology Biology Scholars 2009.
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
Module Five: Viewing Results in SIS. Introduction – Viewing Results Accurately communicating case interpretation to patients is one of the most important.
TREC SCREENING. Characteristics of Disorders Characteristics of Test Well characterized pathogenesis Affects a significant number of infants Undetectable.
Results of the HTA Adequacy Study JHF Smith Royal Hallamshire Hospital, Sheffield BAC Scientific Meeting 2013.
Date of download: 6/3/2016 From: Assessment of Hepatitis C Viremia Using Molecular Amplification Technologies: Correlations and Clinical Implications Ann.
Prevent Disease – Promote Wellness – Improve Quality of Life Michigan update for T Cell Receptor Excision Circle (TREC) analysis for detection of primary.
HBV viral load 측정 및 임상적 의의 진단검사의학과이희주 Content v 임상적 의의 v 측정법.
Biostatistics?.
Pre-Clinical Validation of a Novel, Highly Sensitive Assay to Detect PML-RARα mRNA Using Real-Time Reverse-Transcription Polymerase Chain Reaction  James.
Thymic function in MHC class II–deficient patients
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years  Antonia Kwan, PhD, MRCPCH,
A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens  Iris Babion, Barbara C. Snoek,
Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: The winner is T-cell receptor excision circles 
Limitations and Practical Procedure in BclII-Ig Heavy Chain Gene Rearrangement Real- Time Quantitative Polymerase Chain Reaction  Barbara Dessars, Pierre.
Olivier Gruselle, Thierry Coche, Jamila Louahed 
Presentation transcript:

Model Proficiency Evaluation Survey for TREC Assay in Newborn Screening for SCID Francis K. Lee, Ph.D. Senior Service Fellow (Research Microbiologist) Newborn Screening Translation Research Initiative, CDC Emeritus Professor of Pediatrics, Emory University School of Medicine Newborn Screening Molecular Workshop June 28-30, 2011 National Center for Environmental Health · Division of Laboratory Sciences Newborn Screening and Molecular Biology Branch

DBS Specimen Preparation DNA Extract (from 3 mm punch) Decisions! Decisions! DNA Extract (from 3 mm punch) DNA on DBS (2mm punch) Quantitative ASSAY Primers & Probes Singleplex Multiplex Real time PCR Endpoint PCR 96 /386 well format Calibrator Plasmids Transfected Cells

Classification of TREC Assay Results for NBS reliably interpreted) Screen Negative Screen Positive F/U Required (SCID-like) F/U Required (Result cannot be reliably interpreted) Control Gene Below Cutoff Above Cutoff Indeterminate / Unsatisfactory Below Cutoff Above Cutoff ----------------------- TREC Content

Newborn Screening for SCID CDC Reference Materials Model Performance Evaluation Surveys

DBS Reference Materials for the TREC Assay DBS for Screen Normal Phenotype (3 types) TREC above lower limit of expected range (H, M, L) Control Gene above lower limit of expected range DBS for SCID-Like Phenotype TREC below lower limit of expected range (Very low or undetectable) DBS for Indeterminate/Unsatisfactory Results Control Gene below lower limit of expected range

DBS Reference Materials for TREC Assay DBS made from Serial Dilutions of Cord Blood Cord blood at median of expected range for TREC Dilute into lymphocyte-depleted blood (No detectable TREC) Equal-volume serial dilutions: 100%, 50%, 25%, 12%, 6%, 3% Assay development; Calibration; Assess Comparability of Decision Ranges

No Follow-up Required Follow-up Required

Model Performance Evaluation Surveys (“MPES” = Pilot PT) Sendouts at 4-6 week interval Five DBS w/ prior consensus categorization Additional DBS included for RM evaluation 11 Laboratories currently participating >500 results to date

Report from MPES Lab# 999 No F/U F/U action required TREC Sample ID TREC ------- Final Categorical Result -------- Reference Gene: Beta-actin Comments Cq Copy Number No F/U F/U action required Value per Rxn per µL Bld TREC NL TREC ↓ Ref gene NL Ref gene ↓ A 35.3 121 X   B 37.3 23 28.1 16300 C 36.6 40 27.8 18800 D 34.7 196 E 35.6 95 F Undet. 27.7 20600 G 36.3 48 28.2 15200 H 33.4 557 Cutoff 60 If TREC↓selected, indicate ref erence gene category 10000

CDC Report - Summary of Results MPES#22 Sample ID Sample No F/U F/U required Code TREC NL TREC ↓ Ref gene NL Ref gene ↓ Higher Normal E 9   Lower Normal A SCID -like F Leuko-depleted B CB-cal 4 (25%) G 8 1 CB-cal 5 (12.5%) C 4 5 3 2 CB-cal 6 (6.3%) H CB-cal 7 (3.1%) D 6

CDC NSTRI – SCID Project Team Robert Vogt ( rfv1@cdc.gov 770-488-7895) Francis Lee ( flee1@cdc.gov 770-488-7946) Jennifer Taylor ( vjf6@cdc.gov 770-488-7893) Golriz Yazdanpanah ( czu1@cdc.gov 770-488-7893)